RecruitingNCT05787821

Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)

Persona® OsseoTi® Keel Compatibility Study-A Multicenter Cohort Study A Prospective, Post-market Clinical Follow-up Study to Demonstrate Safety, Performance and Clinical Benefits of the Persona Knee System Portfolio and Its Instrumentation


Sponsor

Zimmer Biomet

Enrollment

760 participants

Start Date

Jun 28, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The main objective of the study is to evaluate the safety, performance and clinical benefits of the Persona implant and its instrumentation in primary total knee arthroplasty


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Patient is of legal age and skeletally mature
  • Patient is willing and able to provide written Informed Consent by signing and dating the Institutional Review Board (IRB) / Ethics Committee (EC) approved Informed Consent document
  • Patient is willing and able to complete scheduled follow-up evaluations as defined in the study protocol
  • Independent of study participation, patient qualifies for either cemented or cementless primary or revision total knee arthroplasty (including salvage of previously failed surgical attempts) based upon physical exam and medical history, and meets the approved indications for use of the commercially available Persona Knee System with appropriately matched Zimmer Biomet components implanted in accordance with product labeling

Exclusion Criteria14

  • Patient is currently participating in any other surgical intervention or pain management study
  • Patient is pregnant or considered a member of a protected (vulnerable) population whose inclusion in the study is inappropriate (e.g. prisoner, mentally incompetent)
  • Patient has a mental or neurological condition who is unwilling or incapable of following postoperative care instructions
  • Patient has a condition which would, in the judgment of the investigator, place the patient at undue risk or interfere with the conduct of the study
  • Patient is institutionalized or is a known drug abuser, a known alcoholic or cannot understand the requirements of study participation
  • Patient is scheduled to undergo simultaneous bilateral total knee arthroplasty
  • Previous history of infection in the affected joint and/or other local/systemic infection that may affect the prosthetic joint
  • Insufficient bone stock on femoral or tibial surfaces
  • Neuropathic arthropathy
  • Osteoporosis or any loss of musculature or neuromuscular disease that compromises the affected limb
  • A stable, painless arthrodesis in a satisfactory functional position
  • Severe instability secondary to the absence of collateral ligament integrity
  • Rheumatoid Arthritis (RA) accompanied by an ulcer of the skin or a history of recurrent breakdown of the skin
  • Patient has a \> 5˚ valgus deformity with a medial collateral ligament (MCL) insufficiency, and the surgeon intends to use the personalized alignment surgical technique

Interventions

DEVICETotal Knee Arthroplasty

Total knee replacement.


Locations(16)

Denver Hip & Knee, Inc.

Parker, Colorado, United States

Foundation for Orthopaedic Research & Education

Tampa, Florida, United States

Northside Hospital, Inc.

Atlanta, Georgia, United States

U of L Health

Louisville, Kentucky, United States

University of Michigan

Ann Arbor, Michigan, United States

Mayo Clinic

Rochester, Minnesota, United States

Mississippi Sports Medicine and Orthopaedic Center

Jackson, Mississippi, United States

New Mexico Orthopaedic Associates

Albuquerque, New Mexico, United States

Syracuse Orthopaedic Specialists

DeWitt, New York, United States

NYU

New York, New York, United States

St. Francis Hospital & Heart Center

Roslyn, New York, United States

OrthoCarolina Research Institute, Inc.

Charlotte, North Carolina, United States

Duke University

Morrisville, North Carolina, United States

Cleveland Clinic

Cleveland, Ohio, United States

UT Health at Houston

Houston, Texas, United States

UVA Health Orthopedic Center

Charlottesville, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05787821


Related Trials